December 12, 2007 |
| Drug Name |
Review Type |
Committee Recommendation |
Prior Approval Status – Final Determination |
Altabax |
New Drug Appeal |
Require Prior Approval |
Prior Approval Required |
Avinza |
PDL Appeal |
Remain Non-Preferred |
Non-Preferred – PDL Class |
Azor |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
Byetta |
New Drug Appeal |
Require Prior Approval |
Prior Approval Required |
Cerefolin NAC |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
Depakote ER |
PDL Appeal |
Remain Non-Preferred |
Non-Preferred – PDL Class |
Exforge |
New Drug Appeal |
Require Prior Approval |
Prior Approval Required |
Invega |
New Drug Initial Review |
Remove Prior Approval Requirement |
Prior Approval requirement removed |
Istalol |
PDL Appeal |
Remain Non-Preferred |
Non-Preferred – PDL Class |
Lantus |
PDL Appeal |
Remain Non-Preferred |
Non-Preferred – PDL Class |
Natelle |
PDL Appeal |
Remain Non-Preferred |
Non-Preferred – PDL Class |
Neupro |
New Drug Initial Review |
Remove Prior Approval Requirement |
Prior Approval requirement removed |
Perforomist |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
Pylera |
New Drug Appeal |
Remove Prior Approval Requirement |
Prior Approval Required |
Veramyst |
New Drug Appeal |
Require Prior Approval |
Prior Approval Required |
Xibrom |
PDL Appeal |
Remain Non-Preferred |
Non-Preferred – PDL Class |
Xyzal |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
Zinotic |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
Zyflo CR |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
